IGSF1, immunoglobulin superfamily member 1, 3547

N. diseases: 66; N. variants: 8
Disease: Tumor Progression ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0178874
Disease: Tumor Progression
Tumor Progression 		0.040 Biomarker phenotype BEFREE Furthermore, we will focus on the contradictory functions of E-cadherin and p120 in the different phases of tumor progression, from carcinoma in situ up to the formation of distant metastasis. 31369816 2020
CUI: C0178874
Disease: Tumor Progression
Tumor Progression 		0.040 AlteredExpression phenotype BEFREE In cancer, reduced p120 expression correlates with reduced E-cadherin function and with tumor progression. 23481205 2013
CUI: C0178874
Disease: Tumor Progression
Tumor Progression 		0.040 Biomarker phenotype BEFREE Here, we discuss past and present findings that implicate p120 in the regulation of cancer progression and highlight opportunities for clinical intervention. 23950111 2013
CUI: C0178874
Disease: Tumor Progression
Tumor Progression 		0.040 GeneticVariation phenotype BEFREE Moreover, in some cases p120 loss appears to be an early event in tumor progression, possibly preceding loss of E-cadherin. 12492499 2002